Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Second Clinical Evaluation of THERANOVA-500 Dialyzer in Chronic Hemodialysis (HD)

NCT03618368 is registered in ClinicalTrials.gov with Réseau de Santé Vitalité Health Network as lead sponsor.

NCT NCT03618368
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03618368 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Second Clinical Evaluation of THERANOVA-500 Dialyzer in Chronic Hemodialysis (HD)
Lead sponsor
Réseau de Santé Vitalité Health Network
Phase
Not applicable
Overall status
Unknown status
Start date
June 25, 2018
Completion date
June 4, 2021
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease on dialysis